Form 8-K - Current report:
SEC Accession No. 0001437749-25-004124
Filing Date
2025-02-18
Accepted
2025-02-18 08:10:21
Documents
16
Period of Report
2025-02-14
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20250217_8k.htm   iXBRL 8-K 34510
2 EXHIBIT 3.1 ex_779422.htm EX-3.1 14754
3 EXHIBIT 99.1 ex_779199.htm EX-99.1 13317
  Complete submission text file 0001437749-25-004124.txt   209025

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA wint-20250214.xsd EX-101.SCH 3410
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20250214_def.xml EX-101.DEF 11805
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20250214_lab.xml EX-101.LAB 15849
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20250214_pre.xml EX-101.PRE 12020
18 EXTRACTED XBRL INSTANCE DOCUMENT wint20250217_8k_htm.xml XML 2946
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 25632800
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)